Inventor · disambiguated record
Jason P. Schrum
Also filed as: SCHRUM JASON · SCHRUM JASON P
30 granted patents·27 pending applications·2,715 citations·filing 2011–2024
98Inventor score
Files withMODERNATX INC26MODERNA THERAPEUTICS INC18modeRNA Therapeutics9SCHRUM JASON P3SCHRUM JASON1
Top patents by PatentIndex Score
57 records- 0199US10772975B2Modified Polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2017·Granted Sep 15, 2020·37 cites·11 claims
- 0299US10064959B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNATX INC·Filed 2017·Granted Sep 4, 2018·45 cites·30 claims
- 0399US9657295B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNA THERAPEUTICS INC·Filed 2016·Granted May 23, 2017·46 cites·20 claims
- 0499US9587003B2Modified polynucleotides for the production of oncology-related proteins and peptidesMODERNA THERAPEUTICS INC·Filed 2016·Granted Mar 7, 2017·67 cites·19 claims
- 0599US9572896B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Feb 21, 2017·75 cites·11 claims
- 0699US9572897B2Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteinsMODERNA THERAPEUTICS INC·Filed 2016·Granted Feb 21, 2017·65 cites·19 claims
- 0799US9504734B2Modified polynucleotides for the production of nuclear proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 29, 2016·56 cites·19 claims
- 0899US9334328B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNA THERAPEUTICS INC·Filed 2013·Granted May 10, 2016·110 cites·10 claims
- 0999US9254311B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Feb 9, 2016·126 cites·14 claims
- 1099US9221891B2In vivo production of proteinsMODERNA THERAPEUTICS INC·Filed 2013·Granted Dec 29, 2015·113 cites·13 claims
- 1199US9181319B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2014·Granted Nov 10, 2015·94 cites·9 claims
- 1298US9428535B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofmodeRNA Therapeutics·Filed 2012·Granted Aug 30, 2016·113 cites·25 claims
- 1398US8999380B2Modified polynucleotides for the production of biologics and proteins associated with human diseasemodeRNA Therapeutics·Filed 2013·Granted Apr 7, 2015·258 cites·16 claims
- 1498US8822663B2Engineered nucleic acids and methods of use thereofSCHRUM JASON P·Filed 2011·Granted Sep 2, 2014·387 cites·4 claims
- 1598US8710200B2Engineered nucleic acids encoding a modified erythropoietin and their expressionSCHRUM JASON P·Filed 2012·Granted Apr 29, 2014·382 cites·14 claims
- 1698US8680069B2Modified polynucleotides for the production of G-CSFmodeRNA Therapeutics·Filed 2013·Granted Mar 25, 2014·180 cites·16 claims
- 1798US8664194B2Method for producing a protein of interest in a primatemodeRNA Therapeutics·Filed 2013·Granted Mar 4, 2014·90 cites·11 claims
- 1897US12357708B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNATX INC·Filed 2024·Granted Jul 15, 2025·1 cites·1 claims
- 1997US9814760B2Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2015·Granted Nov 14, 2017·15 cites·12 claims
- 2097US9464124B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2014·Granted Oct 11, 2016·188 cites·17 claims
- 2197US8754062B2DLIN-KC2-DMA lipid nanoparticle delivery of modified polynucleotidesmodeRNA Therapeutics·Filed 2013·Granted Jun 17, 2014·204 cites·7 claims
- 2296US9782462B2Modified polynucleotides for the production of proteins associated with human diseaseMODERNA THERAPEUTICS INC·Filed 2016·Granted Oct 10, 2017·7 cites·19 claims
- 2396US9447164B2Engineered nucleic acids and methods of use thereofMODERNA THERAPEUTICS INC·Filed 2015·Granted Sep 20, 2016·15 cites·13 claims
- 2495US10022425B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2016·Granted Jul 17, 2018·13 cites·25 claims
- 2595US9937233B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2016·Granted Apr 10, 2018·12 cites·34 claims
- 2695US9827332B2Modified polynucleotides for the production of proteinsMODERNA THERAPEUTICS INC·Filed 2015·Granted Nov 28, 2017·7 cites·33 claims
- 2791US9828416B2Modified polynucleotides for the production of secreted proteinsMODERNATX INC·Filed 2015·Granted Nov 28, 2017·3 cites·24 claims
- 2891US9701965B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2014·Granted Jul 11, 2017·4 cites·16 claims
- 2987US12496358B2Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNATX INC·Filed 2022·Granted Dec 16, 2025·0 cites·1 claims
- 3087US10751386B2Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2018·Granted Aug 25, 2020·2 cites·14 claims
- 3187US2024123035A1Modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2023·Application pending·0 cites
- 3281US2021115101A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2019·Application pending·0 cites
- 3379US2022273766A1Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2021·Application pending·0 cites
- 3479US2021299278A1Modified polynucleotides for the production of biologics and proteins associated with human diseaseMODERNATX INC·Filed 2020·Application pending·0 cites
- 3576US2021236655A1Engineered Nucleic Acids and Methods of Use ThereofMODERNATX INC·Filed 2020·Application pending·0 cites
- 3672US2018086807A1Modified polynucleotides for the production of proteins associated with human diseaseMODERNATX INC·Filed 2017·Application pending·0 cites
- 3772US2020164038A1Modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2019·Application pending·0 cites
- 3872US2019160185A1Modified nucleosides, nucleotides, and nucleic acids, and uses thereofMODERNATX INC·Filed 2018·Application pending·0 cites
- 3971US2019240351A1Modified polynucleotides for the production of proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 4070US2018112221A1Engineered Nucleic Acids and Methods of Use ThereofMODERNATX INC·Filed 2017·Application pending·0 cites
- 4169US2018170990A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2017·Application pending·0 cites
- 4267US2018125937A1Modified nucleoside, nucleotide, and nucleic acid compositionsMODERNATX INC·Filed 2017·Application pending·0 cites
- 4367US2017028085A1Modified polynucleotides for the production of nuclear proteinsMODERNATX INC·Filed 2016·Application pending·0 cites
- 4466US2013102034A1Modified nucleosides, nucleotides, and nucleic acids, and uses thereofSCHRUM JASON P·Filed 2012·Application pending·0 cites
- 4566US2013245103A1Modified polynucleotides for the production of factor ixmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 4666US2013266640A1Modified nucleoside, nucleotide, and nucleic acid compositionsmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 4766US2013244282A1Method of producing antibodiesmodeRNA Therapeutics·Filed 2013·Application pending·0 cites
- 4865US2012237975A1Engineered nucleic acids and methods of use thereofSCHRUM JASON·Filed 2011·Application pending·0 cites
- 4965US2019030129A1Engineered nucleic acids and methods of use thereofMODERNATX INC·Filed 2018·Application pending·0 cites
- 5064US2013156849A1Modified nucleoside, nucleotide, and nucleic acid compositionsmodeRNA Therapeutics·Filed 2012·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jason P. Schrum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →